chang clearanc total unbound etoposid patient liver dysfunct disposit total non-protein-bound etoposid cancer patient etoposid cisplatin combin chemotherapi etoposid plasma concentr specif high-perform liquid chromatographi hplc method plasma protein bind equilibrium dialysi patient wide rang renal function creatinin clearanc hepat function total bilirubin rang mg/dl aspart aminotransferas ast rang iu/l serum albumin rang g/dl mean etoposid total system clearanc differ patient total bilirubin mg/dl versu patient total bilirubin mg/dl t-test trend total clearanc patient abnorm bilirubin valu mean clearanc unbound etoposid patient increas total bilirubin t-test fraction etoposid unbound fu plasma patient increas bilirubin t-test trend total clearanc patient etoposid clearanc total unbound patient measur hepat metastas differ clearanc patient hepat metastas studi explan patient increas bilirubin total system clearanc etoposid patient exposur result pharmacodynam studi total unbound etoposid patient increas bilirubin clinic relev alter etoposid protein bind 